Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer

被引:81
作者
Annunziata, Christina M. [2 ]
O'Shaughnessy, Joyce [1 ]
机构
[1] US Oncol, Baylor Sammons Canc Ctr, Texas Oncol, Dallas, TX 75246 USA
[2] NCI, Med Oncol Branch, Bethesda, MD 20892 USA
关键词
BREAST-CANCER; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; SPORADIC BREAST; STRAND BREAKS; MECHANISMS; INHIBITORS; BRCA1; GENE; INSTABILITY;
D O I
10.1158/1078-0432.CCR-10-0526
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer chemotherapy exploits limitations in repairing DNA damage in order to kill proliferating malignant cells. Recent evidence suggests that cancers within and across tissue types have specific defects in DNA repair pathways, and that these defects may predispose for sensitivity and resistance to various classes of cytotoxic agents. Poly (ADP-ribose) polymerase (PARP) and BRCA proteins are central to the repair of DNA strand breaks and, when defective, lead to the accumulation of mutations introduced by error-prone DNA repair. Breast, ovarian, and other cancers develop in the setting of BRCA deficiency, and these cancers may be more sensitive to cytotoxic agents that induce DNA strand breaks, as well as inhibitors of PARP activity. A series of recent clinical trials has tested whether PARP inhibitors can achieve synthetic lethality in BRCA-pathway-deficient tumors. Future studies must seek to identify sporadic cancers that harbor genomic instability, rendering susceptibility to agents that induce additional and lethal DNA damage. Clin Cancer Res; 16(18); 4517-26. (c) 2010 AACR.
引用
收藏
页码:4517 / 4526
页数:10
相关论文
共 49 条
[1]  
Audeh MW, 2009, J CLIN ONCOL, V27
[2]   Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene [J].
Bartkova, Jirina ;
Tommiska, Johanna ;
Oplustilova, Lenka ;
Aaltonen, Kirsimari ;
Tamminen, Anitta ;
Heikkinen, Tuomas ;
Mistrik, Martin ;
Aittomaki, Kristiina ;
Blomqvist, Carl ;
Heikkila, Paivi ;
Lukas, Jiri ;
Nevanlinna, Heli ;
Bartek, Jiri .
MOLECULAR ONCOLOGY, 2008, 2 (04) :296-316
[3]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[4]   A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers [J].
Carter, Scott L. ;
Eklund, Aron C. ;
Kohane, Isaac S. ;
Harris, Lyndsay N. ;
Szallasi, Zoltan .
NATURE GENETICS, 2006, 38 (09) :1043-1048
[5]   Meta-analysis of BRCA1 and BRCA2 penetrance [J].
Chen, Sining ;
Parmigiani, Giovanni .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) :1329-1333
[6]   DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin [J].
Crul, M ;
van Waardenburg, RCAM ;
Bocxe, S ;
van Eijndhoven, MAJ ;
Pluim, D ;
Beijnen, JH ;
Schellens, JHM .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (02) :275-282
[7]   The power and potential of doxorubicin-DNA adducts [J].
Cutts, SM ;
Nudelman, A ;
Rephaeli, A ;
Phillips, DR .
IUBMB LIFE, 2005, 57 (02) :73-81
[8]   Resistance to therapy caused by intragenic deletion in BRCA2 [J].
Edwards, Stacey L. ;
Brough, Rachel ;
Lord, Christopher J. ;
Natrajan, Rachael ;
Vatcheva, Radost ;
Levine, Douglas A. ;
Boyd, Jeff ;
Reis-Filho, Jorge S. ;
Ashworth, Alan .
NATURE, 2008, 451 (7182) :1111-U8
[9]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921
[10]   Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval [J].
Fong, Peter C. ;
Yap, Timothy A. ;
Boss, David S. ;
Carden, Craig P. ;
Mergui-Roelvink, Marja ;
Gourley, Charlie ;
De Greve, Jacques ;
Lubinski, Jan ;
Shanley, Susan ;
Messiou, Christina ;
A'Hern, Roger ;
Tutt, Andrew ;
Ashworth, Alan ;
Stone, John ;
Carmichael, James ;
Schellens, Jan H. M. ;
de Bono, Johann S. ;
Kaye, Stan B. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15) :2512-2519